Cargando…

Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets

Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia (ITP). However, there are few studies characterizing the capacity and mechanisms of humoral factor–triggered macrophage phagocytosis of plat...

Descripción completa

Detalles Bibliográficos
Autores principales: Norris, Peter A. A., Tawhidi, Zoya, Sachs, Ulrich J., Cserti-Gazdewich, Christine M., Lin, Yulia, Callum, Jeannie, Gil Gonzalez, Lazaro, Shan, Yuexin, Branch, Donald R., Lazarus, Alan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368862/
https://www.ncbi.nlm.nih.gov/pubmed/37042934
http://dx.doi.org/10.1182/bloodadvances.2022009423
_version_ 1785077595927216128
author Norris, Peter A. A.
Tawhidi, Zoya
Sachs, Ulrich J.
Cserti-Gazdewich, Christine M.
Lin, Yulia
Callum, Jeannie
Gil Gonzalez, Lazaro
Shan, Yuexin
Branch, Donald R.
Lazarus, Alan H.
author_facet Norris, Peter A. A.
Tawhidi, Zoya
Sachs, Ulrich J.
Cserti-Gazdewich, Christine M.
Lin, Yulia
Callum, Jeannie
Gil Gonzalez, Lazaro
Shan, Yuexin
Branch, Donald R.
Lazarus, Alan H.
author_sort Norris, Peter A. A.
collection PubMed
description Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia (ITP). However, there are few studies characterizing the capacity and mechanisms of humoral factor–triggered macrophage phagocytosis of platelets using specimens from patients with ITP. Here, we assessed sera from a cohort of 24 patients with ITP for the capacity to trigger macrophage phagocytosis of normal donor platelets and characterized the contribution of humoral factors to phagocytosis. Sera that produced a phagocytosis magnitude greater than a normal human serum mean + 2 standard deviations were considered phagocytosis-positive. Overall, 42% (8/19) of MHC I alloantibody-negative ITP sera were phagocytosis-positive. The indirect monoclonal antibody immobilization of platelet antigens assay was used to detect immunoglobulin G (IgG) autoantibodies to glycoproteins (GP)IIb/IIIa, GPIb/IX, and GPIa/IIa. Autoantibody-positive sera triggered a higher mean magnitude of phagocytosis than autoantibody-negative sera. Phagocytosis correlated inversely with platelet counts among autoantibody-positive patients but not among autoantibody-negative patients. Select phagocytosis-positive sera were separated into IgG-purified and -depleted fractions via protein G and reassessed for phagocytosis. Phagocytosis was largely retained in the purified IgG fractions. In addition, we assessed serum concentrations of C-reactive protein, serum amyloid P, and pentraxin 3 as potential phagocytosis modulators. Pentraxin 3 concentrations correlated inversely with platelet counts among patients positive for autoantibodies. Taken together, sera from approximately half of the patients with ITP studied triggered macrophage phagocytosis of platelets beyond a normal level. An important role for antiplatelet autoantibodies in phagocytosis is supported; a role for pentraxins such as pentraxin 3 may be suggested.
format Online
Article
Text
id pubmed-10368862
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-103688622023-07-27 Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets Norris, Peter A. A. Tawhidi, Zoya Sachs, Ulrich J. Cserti-Gazdewich, Christine M. Lin, Yulia Callum, Jeannie Gil Gonzalez, Lazaro Shan, Yuexin Branch, Donald R. Lazarus, Alan H. Blood Adv Platelets and Thrombopoiesis Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia (ITP). However, there are few studies characterizing the capacity and mechanisms of humoral factor–triggered macrophage phagocytosis of platelets using specimens from patients with ITP. Here, we assessed sera from a cohort of 24 patients with ITP for the capacity to trigger macrophage phagocytosis of normal donor platelets and characterized the contribution of humoral factors to phagocytosis. Sera that produced a phagocytosis magnitude greater than a normal human serum mean + 2 standard deviations were considered phagocytosis-positive. Overall, 42% (8/19) of MHC I alloantibody-negative ITP sera were phagocytosis-positive. The indirect monoclonal antibody immobilization of platelet antigens assay was used to detect immunoglobulin G (IgG) autoantibodies to glycoproteins (GP)IIb/IIIa, GPIb/IX, and GPIa/IIa. Autoantibody-positive sera triggered a higher mean magnitude of phagocytosis than autoantibody-negative sera. Phagocytosis correlated inversely with platelet counts among autoantibody-positive patients but not among autoantibody-negative patients. Select phagocytosis-positive sera were separated into IgG-purified and -depleted fractions via protein G and reassessed for phagocytosis. Phagocytosis was largely retained in the purified IgG fractions. In addition, we assessed serum concentrations of C-reactive protein, serum amyloid P, and pentraxin 3 as potential phagocytosis modulators. Pentraxin 3 concentrations correlated inversely with platelet counts among patients positive for autoantibodies. Taken together, sera from approximately half of the patients with ITP studied triggered macrophage phagocytosis of platelets beyond a normal level. An important role for antiplatelet autoantibodies in phagocytosis is supported; a role for pentraxins such as pentraxin 3 may be suggested. The American Society of Hematology 2023-04-14 /pmc/articles/PMC10368862/ /pubmed/37042934 http://dx.doi.org/10.1182/bloodadvances.2022009423 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Platelets and Thrombopoiesis
Norris, Peter A. A.
Tawhidi, Zoya
Sachs, Ulrich J.
Cserti-Gazdewich, Christine M.
Lin, Yulia
Callum, Jeannie
Gil Gonzalez, Lazaro
Shan, Yuexin
Branch, Donald R.
Lazarus, Alan H.
Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
title Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
title_full Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
title_fullStr Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
title_full_unstemmed Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
title_short Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
title_sort serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
topic Platelets and Thrombopoiesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368862/
https://www.ncbi.nlm.nih.gov/pubmed/37042934
http://dx.doi.org/10.1182/bloodadvances.2022009423
work_keys_str_mv AT norrispeteraa serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT tawhidizoya serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT sachsulrichj serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT csertigazdewichchristinem serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT linyulia serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT callumjeannie serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT gilgonzalezlazaro serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT shanyuexin serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT branchdonaldr serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets
AT lazarusalanh serumfromhalfofpatientswithimmunethrombocytopeniatriggermacrophagephagocytosisofplatelets